Arriving in the arena of obesity treatment, retatrutide presents a unique approach. Unlike many current medications, retatrutide operates as a twin agonist, simultaneously engaging both GLP-like peptide-1 (GLP-1) and https://pennyuphl655517.blue-blogs.com/46485969/this-novel-retatrutide-this-glp-gip-binding-site-agonist